Biopsy Devices Market Size

Biopsy Devices Market Size

Biopsy Devices Market size exceeded USD 2 billion in 2022 and is anticipated to depict over 6% CAGR through 2023-2032. Increasing prevalence of breast cancer along with strong awareness about innovative diagnostic equipment availability will boost the global industry growth.

To get key market trends

  Download Free Sample

The introduction of multiple educational campaigns has increased awareness about cancer and its diagnosis, while the risk of breast cancer has also risen over the years. According to the American Cancer Society's report, women in the United States have a 12% lifetime risk of developing breast cancer. These factors are expected to drive the demand for biopsy equipment and supplies, which are used to remove small pieces of breast tissue to detect cancer cells. The general population is also becoming more aware of the availability of innovative diagnostic equipment, which is likely to further boost the development of breast biopsy devices.

Despite the benefits of using biopsy devices, randomized trials have shown that there are potential complications associated with their use. For example, a trial conducted in Europe identified major issues related to prostate needle biopsy, including fever episodes, urinary tract infection, transitory bacteremia, urinary retention, and sepsis. In addition, excessive bleeding, drainage from biopsy sites, and swelling due to infections or sepsis have also been reported among users, which may limit the use of needle biopsy devices to some extent.